Tandem Diabetes Announces NEJM Publication Of Control-IQ+ Trial For Type 2 Diabetes, Showing Significant A1C Reductions Of 0.9% Overall And 2.3% For A1C ≥9%, Meeting Primary Endpoint

BenzingaMar 19 10:02 ET

TD Cowen Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Cuts Target Price to $27

Moomoo NewsMar 19 02:31 ET · Ratings

Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes With Control-IQ+ AID Technology in Type 2 Diabetes

Tandem Diabetes Care Mar 19 00:00 ET

Express News | Tandem Diabetes Care Inc : TD Cowen Cuts Target Price to $27 From $40

ReutersMar 18 23:56 ET

Express News | Tandem Diabetes Care Launches New Control-Iq+ Automated Insulin Delivery Technology in the United States

ReutersMar 18 16:05 ET

Barclays Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $53

Moomoo NewsMar 18 04:33 ET · Ratings

Barclays Remains a Buy on Tandem Diabetes Care (TNDM)

TipRanksMar 18 03:55 ET · Ratings

Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States

Tandem Diabetes Care Mar 18 00:00 ET

Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup

Dow JonesMar 17 16:53 ET

Executive VP & COO of Tandem Diabetes Care Jean-Claude Kyrillos Buys More Stock

Simply Wall StMar 13 06:25 ET

Reasons to Hold TNDM Stock in Your Portfolio for Now

Zacks Mar 11 09:45 ET

Tandem Diabetes Care: A Buy Rating Backed by Growth Potential and Valuation Opportunity

TipRanksMar 10 09:05 ET · Ratings

Citi Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $24

Moomoo NewsMar 7 07:31 ET · Ratings

This H.B. Fuller Company Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

BenzingaMar 5 10:53 ET

Tandem Diabetes Care Cut to Equal-Weight From Overweight by Morgan Stanley

Dow JonesMar 5 08:42 ET · Ratings

Morgan Stanley Downgrades Tandem Diabetes Care(TNDM.US) to Hold Rating, Cuts Target Price to $22

Moomoo NewsMar 5 06:31 ET · Ratings

Advisor360° Introduces Tandem: A CRM+ for Independent Financial Advisors

BusinesswireMar 4 09:30 ET

Tandem Diabetes Care Cut to Neutral From Buy by Citigroup

Dow JonesMar 4 06:29 ET · Ratings

Citi Downgrades Tandem Diabetes Care(TNDM.US) to Hold Rating, Cuts Target Price to $24

Moomoo NewsMar 4 05:33 ET · Ratings

Bernstein Maintains Tandem Diabetes Care(TNDM.US) With Hold Rating, Maintains Target Price $25

Moomoo NewsMar 3 19:32 ET · Ratings